Basic Information
RNALocate ID: | RLID:11004163 |
RNA Symbol: | hsa-miR-665 |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-665 |
RNA ID: | miRBase:MIMAT0004952 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 24009880 |
Tissue/Cell Line: | Human mast cell line (HMC-1) |
Method: | Microarray |
Description: | In the exosomes, 116 microRNAs were identified and 134 microRNAs were identified in the donor HMC-1 cells (Fig. 3a and 3b, Table I and Additional Information, Table S16). Data are collected from Table 1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11004162 | Exosome | Plasma | 23663360 |
RLID:11004164 | Exosome | K562 cells | 24460325 |
RLID:11004165 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000728 | Microvesicle | Mesenchymal stem cells|Urine | |
RLID-D:11001603 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-mir-665 | Pterygium | MNDR-E-MI-66173 |
MNDR | hsa-miR-665 | High-grade serous ovarian carcinoma | MNDR-E-MI-66174 |
MNDR | hsa-miR-665 | Lymphoma | MNDR-E-MI-66175 |
MNDR | hsa-miR-665 | Estrogen-receptor positive breast cancer | MNDR-E-MI-66176 |
MNDR | hsa-miR-665 | Estrogen-receptor negative breast cancer | MNDR-E-MI-66177 |
MNDR | hsa-miR-665 | Progesterone-receptor positive breast cancer | MNDR-E-MI-66178 |
MNDR | hsa-miR-665 | Progesterone-receptor negative breast cancer | MNDR-E-MI-66179 |
MNDR | hsa-miR-665 | Her2-receptor positive breast cancer | MNDR-E-MI-66180 |
MNDR | hsa-miR-665 | Breast cancer luminal | MNDR-E-MI-66181 |
MNDR | hsa-miR-665 | Prostate cancer | MNDR-E-MI-66182 |
MNDR | hsa-miR-665 | Gastric cancer | MNDR-E-MI-66183 |
MNDR | hsa-miR-665 | Alzheimer disease | MNDR-E-MI-66184 |
MNDR | hsa-miR-665 | Intracranial aneurysm | MNDR-E-MI-66185 |
MNDR | hsa-mir-665 | Parkinson disease | MNDR-E-MI-66186 |
MNDR | hsa-miR-665 | Parkinson disease | MNDR-E-MI-66187 |
MNDR | hsa-miR-665 | Basal-like breast cancer | MNDR-E-MI-66188 |
MNDR | hsa-miR-665 | Pancreatic cancer | MNDR-E-MI-66189 |
MNDR | hsa-miR-665 | Colon cancer | MNDR-E-MI-66190 |
MNDR | hsa-miR-665 | Relapsing-remitting multiple sclerosis | MNDR-E-MI-66191 |
MNDR | hsa-miR-665 | Malignant glioma | MNDR-E-MI-66192 |
MNDR | hsa-miR-665 | Amyotrophic lateral sclerosis | MNDR-E-MI-66193 |
MNDR | hsa-miR-665 | Temporal lobe epilepsy | MNDR-E-MI-66194 |
MNDR | hsa-miR-665 | Osteosarcoma | MNDR-E-MI-66195 |
MNDR | hsa-mir-665 | Osteosarcoma | MNDR-E-MI-66196 |
MNDR | hsa-miR-665 | Liver cancer | MNDR-E-MI-66197 |
MNDR | hsa-miR-665 | Lung adenocarcinoma | MNDR-E-MI-66198 |
MNDR | hsa-miR-665 | Ovarian carcinoma | MNDR-E-MI-66199 |
MNDR | hsa-miR-665 | Pancreatic adenocarcinoma | MNDR-E-MI-66200 |
MNDR | hsa-miR-665 | Myasthenia gravis autoimmune experimental | MNDR-E-MI-66201 |
MNDR | hsa-miR-665 | Biliary tract cancer | MNDR-E-MI-66202 |
MNDR | hsa-miR-665 | Cholangiocarcinoma | MNDR-E-MI-66203 |
MNDR | hsa-miR-665 | Esophageal cancer | MNDR-E-MI-66204 |
MNDR | hsa-miR-665 | Synovial sarcoma | MNDR-E-MI-66205 |
MNDR | hsa-mir-665 | Chronic heart failure | MNDR-E-MI-66206 |
MNDR | hsa-miR-665 | Hepatocellular carcinoma | MNDR-E-MI-66207 |
MNDR | hsa-miR-665 | Malignant pleural mesothelioma | MNDR-E-MI-66208 |
MNDR | hsa-miR-665 | Retinoblastoma | MNDR-E-MI-66209 |
MNDR | hsa-miR-665 | Hodgkin lymphoma | MNDR-E-MI-66210 |
MNDR | hsa-miR-665 | Colorectal cancer | MNDR-E-MI-66211 |
MNDR | hsa-miR-665 | Nasopharynx carcinoma | MNDR-E-MI-66212 |
MNDR | hsa-miR-665 | Nasopharyngeal cancer | MNDR-E-MI-66213 |
MNDR | hsa-miR-665 | Stroke lacunar | MNDR-E-MI-66214 |
MNDR | hsa-miR-665 | Breast cancer her3+ negative | MNDR-E-MI-66215 |
MNDR | hsa-mir-665 | Stroke susceptibility | MNDR-E-MI-66216 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | CD274 | Homo sapiens | RR00300240 |
TOP